Bioactive peptides derived from vascular endothelial cell extracellular matrices promote microvascular morphogenesis and wound healing in vitro

Wound Repair and Regeneration

Volumn 19, Issue 1, 2011, Pages 59-70

  Demidova Rice, Tatiana N ^a   Geevarghese, Anita ^a   Herman, Ira M ^a  

^a TUFTS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 1; COLLAGEN TYPE 2; COLLAGEN TYPE 3; COLLAGEN TYPE 4; COLLAGEN TYPE 5; COLLAGENASE; FIBRILLIN 1; POLYPEPTIDE; TENASCIN;

ANGIOGENESIS; ANIMAL CELL; ARTICLE; CLOSTRIDIUM HISTOLYTICUM; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; IN VITRO STUDY; MASS SPECTROMETRY; MICROVASCULATURE; MODEL; MORPHOGENESIS; NONHUMAN; PRIORITY JOURNAL; THREE DIMENSIONAL IMAGING; VASCULAR ENDOTHELIUM; WOUND HEALING;

CAPILLARIES; CELL CULTURE TECHNIQUES; CLOSTRIDIUM HISTOLYTICUM; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; EXTRACELLULAR MATRIX; HUMANS; MICROBIAL COLLAGENASE; MORPHOGENESIS; NEOVASCULARIZATION, PHYSIOLOGIC; WOUND HEALING;

EID: 78751558921     PISSN: 10671927     EISSN: 1524475X     Source Type: Journal    
DOI: 10.1111/j.1524-475X.2010.00642.x     Document Type: Article

References (39)

1. Falanga V., Wound healing and its impairment in the diabetic foot. Lancet 2005; 366: 1736-43.
2. Liu ZJ, Velazquez OC., Hyperoxia, endothelial progenitor cell mobilization, and diabetic wound healing. Antioxid Redox Signal 2008; 10: 1869-82.
3. Beitz JG, Kim IS, Calabresi P, Frackelton AR Jr., Human microvascular endothelial cells express receptors for platelet-derived growth factor. Proc Natl Acad Sci USA 1991; 88: 2021-5.
4. Li J, Zhang YP, Kirsner RS., Angiogenesis in wound repair: angiogenic growth factors and the extracellular matrix. Microsc Res Tech 2003; 60: 107-14.
5. Avraamides CJ, Garmy-Susini B, Varner JA., Integrins in angiogenesis and lymphangiogenesis. Nat Rev Cancer 2008; 8: 604-17.
6. Roy R, Zhang B, Moses MA., Making the cut: protease-mediated regulation of angiogenesis. Exp Cell Res 2006; 312: 608-22.
7. Bergers G, Brekken R, McMahon G, Vu TH, Itoh T, Tamaki K, Tanzawa K, Thorpe P, Itohara S, Werb Z, Hanahan D., Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nat Cell Biol 2000; 2: 737-44.
8. Rhodes JM, Simons M., The extracellular matrix and blood vessel formation: not just a scaffold. J Cell Mol Med 2007; 11: 176-205.
9. Xu J, Rodriguez D, Petitclerc E, Kim JJ, Hangai M, Moon YS, Davis GE, Brooks PC., Proteolytic exposure of a cryptic site within collagen type IV is required for angiogenesis and tumor growth in vivo. J Cell Biol 2001; 154: 1069-7.
10. Bellon G, Martiny L, Robinet A., Matrix metalloproteinases and matrikines in angiogenesis. Crit Rev Oncol Hematol 2004; 49: 203-20.
11. Robinet A, Fahem A, Cauchard JH, Huet E, Vincent L, Lorimier S, Antonicelli F, Soria C, Crepin M, Hornebeck W, Bellon G., Elastin-derived peptides enhance angiogenesis by promoting endothelial cell migration and tubulogenesis through upregulation of MT1-MMP. J Cell Sci 2005; 118: 343-56.
12. Herman IM., Molecular mechanisms regulating the vascular endothelial cell motile response to injury. J Cardiovasc Pharmacol 1993; 22 (Suppl. 4): S25-36.
13. Riley KN, Herman IM., Collagenase promotes the cellular responses to injury and wound healing in vivo. J Burns Wounds 2005; 4: 112-124.
14. Healy AM, Herman IM., Density-dependent accumulation of basic fibroblast growth factor in the subendothelial matrix. Eur J Cell Biol 1992; 59: 56-67.
15. Gitlin JD, D'Amore PA., Culture of retinal capillary cells using selective growth media. Microvasc Res 1983; 26: 74-80.
16. Healy AM, Herman IM., Preparation of fluorescent basic fibroblast growth factor: localization in living retinal microvascular endothelial cells. Exp Eye Res 1992; 55: 663-9.
17. Murray JC., Angiogenesis protocols. Totowa, NJ: Humana Press, 2001, 267pp.
18. Helmbold P, Nayak RC, Marsch WC, Herman IM., Isolation and in vitro characterization of human dermal microvascular pericytes. Microvasc Res 2001; 61: 160-5.
19. Herman IM, Castellot JJ Jr., Regulation of vascular smooth muscle cell growth by endothelial-synthesized extracellular matrices. Arteriosclerosis 1987; 7: 463-9.
20. Yates JR III, Eng JK, McCormack AL, Schieltz D., Method to correlate tandem mass spectra of modified peptides to amino acid sequences in the protein database. Anal Chem 1995; 67: 1426-3.
21. Fields CG, Lloyd DH, Macdonald RL, Otteson KM, Noble RL., HBTU activation for automated Fmoc solid-phase peptide synthesis. Pept Res 1991; 4: 95-101.
22. Durham JT, Herman IM., Inhibition of angiogenesis in vitro: a central role for beta-actin dependent cytoskeletal remodeling. Microvasc Res 2009; 77: 281-8.
23. Cross MJ, Claesson-Welsh L., FGF and VEGF function in angiogenesis: signalling pathways, biological responses and therapeutic inhibition. Trends Pharmacol Sci 2001; 22: 201-7.
24. Herman IM, Leung A., Creation of human skin equivalents for the in vitro study of angiogenesis in wound healing. Methods Mol Biol 2009; 467: 241-8.
25. Yost JC, Herman IM., Substratum-induced stress fiber assembly in vascular endothelial cells during spreading in vitro. J Cell Sci 1990; 95 (Part 3): 507-20.
26. Kleinman HK, Martin GR., Matrigel: basement membrane matrix with biological activity. Semin Cancer Biol 2005; 15: 378-86.
27. Ramundo J, Gray M., Enzymatic wound debridement. J Wound Ostomy Continence Nurs 2008; 35: 273-80.
28. Bornstein P., Comparative sequence studies of rat skin and tendon collagen. I. Evidence for incomplete hydroxylation of individual prolyl residues in the normal proteins. Biochemistry 1967; 6: 3082-93.
29. Fouser L, Iruela-Arispe L, Bornstein P, Sage EH., Transcriptional activity of the alpha 1(I)-collagen promoter is correlated with the formation of capillary-like structures by endothelial cells in vitro. J Biol Chem 1991; 266: 18345-51.
30. Takeda K, Shiba H, Mizuno N, Hasegawa N, Mouri Y, Hirachi A, Yoshino H, Kawaguchi H, Kurihara H., Brain-derived neurotrophic factor enhances periodontal tissue regeneration. Tissue Eng 2005; 11: 1618-29.
31. Weber E, Rossi A, Solito R, Sacchi G, Agliano' M, Gerli R., Focal adhesion molecules expression and fibrillin deposition by lymphatic and blood vessel endothelial cells in culture. Microvasc Res 2002; 64: 47-55.
32. Ishitsuka T, Ikuta T, Ariga H, Matsumoto K., Serum tenascin-X strongly binds to vascular endothelial growth factor. Biol Pharm Bull 2009; 32: 1004-11.
33. Sabatier L, Chen D, Fagotto-Kaufmann C, Hubmacher D, McKee MD, Annis DS, Mosher DF, Reinhardt DP., Fibrillin assembly requires fibronectin. Mol Biol Cell 2009; 20: 846-58.
34. Burch GH, Gong Y, Liu W, Dettman RW, Curry CJ, Smith L, Miller WL, Bristow J., Tenascin-X deficiency is associated with Ehlers-Danlos syndrome. Nat Genet 1997; 17: 104-8.
35. Egging D, van Vlijmen-Willems I, van Tongeren T, Schalkwijk J, Peeters A., Wound healing in tenascin-X deficient mice suggests that tenascin-X is involved in matrix maturation rather than matrix deposition. Connect Tissue Res 2007; 48: 93-8.
36. Radice M, Brun P, Bernardi D, Fontana C, Cortivo R, Abatangelo G., Clostridial collagenase releases bioactive fragments from extracellular matrix molecules. J Burn Care Rehabil 1999; 20: 282-91.
37. Postlethwaite AE, Seyer JM, Kang AH., Chemotactic attraction of human fibroblasts to type I, II, and III collagens and collagen-derived peptides. Proc Natl Acad Sci USA 1978; 75: 871-5.
38. Laskin DL, Kimura T, Sakakibara S, Riley DJ, Berg RA., Chemotactic activity of collagen-like polypeptides for human peripheral blood neutrophils. J Leukoc Biol 1986; 39: 255-66.
39. Tran KT, Lamb P, Deng JS., Matrikines and matricryptins: implications for cutaneous cancers and skin repair. J Dermatol Sci 2005; 40: 11-20.